The clinical-immunological analysis of a specific and combined immunotherapy of patients with cervical cancer
- Authors: Kenbayeva D.K.1, Lazarev A.F.2
-
Affiliations:
- City Oncology Dispensary, Astana, Republic of Kazakhstan
- Altai Branch, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Barnaul
- Issue: No 3-4 (2012)
- Pages: 147-150
- Section: GYNECOLOGY. TREATMENT
- Published: 24.09.2012
- URL: https://ojrs.abvpress.ru/ojrs/article/view/130
- DOI: https://doi.org/10.17650/1994-4098-2012-0-3-4-147-150
- ID: 130
Cite item
Full Text
Abstract
Research objective is the comparative assessment of efficiency of two various ways of an immunotherapy of patients with cervical cancer. 57 patients with cervical cancer, the III stages, distributed on 3 groups – combined radiotherapy, a combination of a radiotherapy and specific immunotherapy, and also a radiotherapy, specific and adaptive immunotherapy are surveyed. Clinical efficiency of treatment was estimated by means of primary tumor regression and 3-year survival rate. The scheme of combined immunotherapy was shown to possess the most clinical efficiency. Positive dynamics of cell immunity indicators was accompanied to clinical efficiency of treatment.
Keywords
About the authors
D. K. Kenbayeva
City Oncology Dispensary, Astana, Republic of Kazakhstan
Author for correspondence.
Email: dikenb@mail.ru
Russian Federation
A. F. Lazarev
Altai Branch, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, BarnaulRussian Federation
References
Supplementary files

